WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 9.00p on 06-11-2026 at 18:55:11 |
|---|---|
| Change | 0.05p 0.56% |
| Buy | 9.00p |
| Sell | 8.90p |
| Last Trade: | Buy 50,000.00 at 9.00p |
| Day's Volume: | 405,219 |
| Last Close: | 9.00p |
| Open: | 8.95p |
| ISIN: | GB0008025412 |
| Day's Range | 8.90p - 9.10p |
| 52wk Range: | 6.72p - 10.70p |
| Market Capitalisation: | £104.02m |
| VWAP: | 9.055292p |
| Shares in Issue: | 1.16b |
SIG (SHI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 50,000 | 9.00p | Suspected BUY Trade |
16:47:40 - 06-Nov-26 |
| Buy* | 157 | 9.00p | Suspected BUY Trade |
16:35:13 - 06-Nov-26 |
| Sell* | 21,066 | 8.90p | Automatic Execution |
16:28:00 - 06-Nov-26 |
| Buy* | 55,337 | 8.978p | Ordinary |
16:17:49 - 06-Nov-26 |
| Buy* | 245 | 9.00p | SI Trade |
16:16:00 - 06-Nov-26 |
| Sell* | 13,785 | 8.94p | Automatic Execution |
16:16:00 - 06-Nov-26 |
| Sell* | 12,772 | 8.94p | Automatic Execution |
16:16:00 - 06-Nov-26 |
| Buy* | 508 | 9.00p | SI Trade |
16:15:56 - 06-Nov-26 |
| Buy* | 1,032 | 9.00p | Automatic Execution |
16:15:56 - 06-Nov-26 |
| Buy* | 46 | 9.10p | Automatic Execution |
16:12:32 - 06-Nov-26 |
SIG (SHI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2026 3:31 pm | RNS | Director/PDMR Shareholding |
| 21st Oct 2026 7:00 am | RNS | NED & Chair of Audit & Risk Committee Appointment |
| 14th Oct 2026 4:08 pm | RNS | Director/PDMR Shareholding |
| 9th Oct 2026 7:00 am | RNS | Chief Executive succession |
| 5th Oct 2026 3:51 pm | RNS | Director/PDMR Shareholding |
| 17th Aug 2026 4:19 pm | RNS | Holding(s) in Company |
| 6th Aug 2026 4:30 pm | RNS | Holding(s) in Company |
| 4th Aug 2026 7:00 am | RNS | Results for the six months to 30 June 2026 |
| 16th Jul 2026 7:08 am | RNS | Post-close Trading Update |
| 8th Jun 2026 4:44 pm | RNS | Director/PDMR Shareholding |